Artixio

Regulatory Affairs Consulting Services in Vietnam

We offer complete regulatory affairs support in Vietnam, including DAV submissions, in-country representation, and tailored regulatory solutions for life sciences and healthcare industries.

Vietnam Regulatory Affairs Support

Vietnam’s got close to 100 million people and the healthcare market here’s been moving quick in the last few years. If you’re trying to get a product in, there’s the forms, the approvals, a few steps that don’t always run the same way every time. It helps a lot to have someone local who already knows the process — the language bits, which desk to send what to, and how to keep things from stalling. That way, you’re not stuck waiting longer than you need to before it’s out there.

Vietnam Healthcare Regulatory Affairs Outsourcing Market & Solutions

Vietnam’s growing life sciences scene is driving demand for local expertise. The Vietnam healthcare regulatory affairs outsourcing market offers end-to-end support—from planning and translations to dossier prep, submissions, and approvals—making regulatory solutions faster and easier for businesses.

We start by checking how the Vietnam healthcare regulatory affairs outsourcing market is shaking out — tallies, timelines, what’s working right now.

Next, we figure out the right path for you: which submissions to prepare (drug or device), which formats (ACTD, CTD), and who you need to talk to.

Then comes the paperwork — translated, formatted, double-checked. That means everything from dossier prep to regulatory solutions that adapt to what the authorities expect today.

 We don’t just sit behind a screen. We team up with trusted locals — your Vietnam regulatory affairs and submission services arm on the ground — handling submissions, follow-ups, and any curveballs that pop up.

We don’t just sit behind a screen. We team up with trusted locals — your Vietnam regulatory affairs and submission services arm on the ground — handling submissions, follow-ups, and any curveballs that pop up.

Pre-Submission Preparation

Dossier Compilation and Localization

Submission and Coordination

Review and Clarification Process

Product Approval

Post-Market Responsibilities

Product Approval Timelines in Vietnam

Timelines may extend if translation, classification, or local representation requirements are not met at the time of submission. Working with compliance consulting regulatory affairs experts in Vietnam can help address these gaps early and keep the registration process on track.

Products Timelines
New Pharmaceuticals 9–12 months
Generics 6–9 months
Medical Devices (Class A) 7–10 working days
Medical Devices (Class B to D) 6–12 months
Cosmetics 2–4 weeks (notification)
Nutritional/Supplements 3–5 months
Biologics 9–15 months
Veterinary Products 6–10 months

Why Artixio As Your Regulatory Consultant In Vietnam?

5000+ regulatory submissions handled across Southeast Asia
100+ pharmaceutical, device & supplement brands supported
ACTD, CTD, and CSDT dossiers customised to DAV & MOH formats
35+ years of regulatory experience in ASEAN markets
Vietnamese translation, MAH, and post-approval services under one roof

Our team works on the ground with the Drug Administration of Vietnam (DAV), combining local know-how with global compliance standards to get your product approved—fast and without unnecessary back-and-forth. Talk to our Vietnam regulatory affairs consultant today for a seamless approval process.

FAQs

1. Is a legal agent required in Vietnam?
Yes, foreign manufacturers cannot directly register products with the DAV or other agencies. A Vietnamese legal representative or Marketing Authorization Holder (MAH) is required for all submissions.
Most registrations are valid for five years. Renewal applications should be submitted at least six months before the registration expiration to avoid a lapse in market presence.
No, each product must have its own registration dossier and Market Authorization. Product line extensions or different formulations require separate filings or variation submissions.
It is not always required. For generics and drugs with prior international approvals, bioequivalence data may suffice. New molecules, biologics, or locally untested therapies may require clinical data or bridging studies.
Yes, traditional or herbal components are reviewed for safety and local acceptability. Some may be restricted or require additional documentation or testing.

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Regulatory Affairs Services Across Multiple Industries

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Affairs Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles